DFB Pharmaceuticals

BionorthTX Names Pharma Entrepreneur, Investor, and Philanthropist as Stone Award Recipient

by | Sep 9, 2019
Among the contributions of recipient Paul Dorman, the chairman and CEO of DFB Pharmaceuticals, is paying for the first-year tuition of the entire inaugural class of M.D. students at the TCU and UNTHSC School of Medicine in Fort Worth.
Could NanOlogy’s Nanoparticles Reshape Cancer Treatment?
by | Sep 13, 2017
The technique uses "naked" nanoparticles that can be injected directly into a tumor for greater efficacy and safety.